Notably, we recently reported that obesity‐induced chronic inflammation, facilitated by high ANGPTL2 expression, suppresses the efficacy of ICIs (Yumoto et al. 2024). Here, ANGPTL2 is linked to obesity due to melanocortin 4 receptor deficiency.